C. R. Bard, Inc., BCR is in the exchange NYSE and its industry is Medical Instruments & Supplies in the sector of Healthcare. Based in USA, C. R. Bard, Inc., BCR has a market cap of 15873.66. Since its IPO date on the 4/6/1983, C. R. Bard, Inc., BCR performance year to date is 14.50%. Today C. R. Bard, Inc., BCR has gained -1.70%, with a current price of 212.2.
Ownership of the company is 0.20% for insider ownership while institutional ownership is 89.10%. The management of the company have seen the company have a payout ratio of 14.40%. Return of assets are at 9.80%, with return on investment at 6.40%.
In terms of debt levels and profit levels, C. R. Bard, Inc., BCR is seeing a long-term debt/equity of 0.95. While Total debt/equity is 0.95. With a profit margin of 13.90%, this is combined with a gross margin of 62.90%, and operating margin of 18.40%. C. R. Bard, Inc. ability to meet debt levels, with a current ratio of 2.6, while the quick ratio is 2.1.
For the last year C. R. Bard, Inc., BCR has seen a EPS growth of -52.90%. A performance for the year of 16.11%. The 52-week high is -11.17%, and the 52-week low is 23.81%. The average volume for C. R. Bard, Inc., BCR is 60685.
With a target price of 242.86, can C. R. Bard, Inc., BCR reach this target? Looking at the value indicators of C. R. Bard, Inc., BCR. C. R. Bard, Inc. has a P/E of 28.79 and a forward P/E of 19.02. Perhaps the more useful indicator than P/E, is PEG which has a value of 2.5. C. R. Bard, Inc. also has a P/S and a P/B of 4.39 and 9.29 respectively. For P/cash, C. R. Bard, Inc. has a value of 15.93, while it is 53.11 for P/free cash flow.
At the current price of 212.2, C. R. Bard, Inc. has a dividend yield of 0.48%. We see a return on equity of 32.20%.
Looking more long-term C. R. Bard, Inc., is projected to get an EPS growth for the next five years of 11.50%. In the short-term an EPS growth of 10.57% in the next year is forecasted. This is after a EPS growth of -52.90% for this year and for the last five years a -19.80% growth has been seen.